Keywords: -sciclone, pharmaceuticals, zadaxin, approvals, sciclone, lead, hepatitis

-SciClone Pharmaceuticals' Zadaxin approvals

Article | 18 March 1999

- SciClone Pharmaceuticals' lead hepatitis product, Zadaxin (thymosinalpha 1), has been approved in Vietnam for the treatment of hepatitis B. Meantime, Singapore ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Thymalfasin

Zadaxin

Go to drug listing